Deva Holding A.S

Short Term Long Term Short Term Comparison Long Term Comparison

DEVA
1d0.61%
1w0.61%
1m-4.80%
1y86.17%
DEVA
1y86.17%
5y1,563.72%
10y4,106.21%
20y23,341.40%

Bitcoin
-0.82%
-9.09%
-6.40%
106.24%
Bitcoin
106.24%
1,146.32%
11,770.30%
0.00%

Ethereum
-0.90%
-11.75%
-14.49%
45.57%
Ethereum
45.57%
1,828.08%
0.00%
0.00%

Gold
0.26%
2.56%
11.41%
20.52%
Gold
20.52%
88.92%
85.82%
499.35%

Silver
0.47%
4.25%
15.38%
14.30%
Silver
14.30%
94.94%
48.08%
306.93%

Apple
-2.19%
1.78%
0.04%
5.09%
Apple
5.09%
260.11%
-66.73%
39,041.00%

Amazon
-1.68%
-1.44%
4.92%
78.52%
Amazon
78.52%
96.45%
-43.46%
7,943.96%

Microsoft
-1.96%
-2.97%
-0.67%
45.75%
Microsoft
45.75%
259.81%
923.86%
2,532.12%

S&P 500
-1.20%
-2.84%
-1.08%
22.34%
S&P 500
22.34%
74.12%
171.80%
346.13%

Dow & Jones
-0.65%
-2.95%
-2.53%
11.36%
Dow & Jones
11.36%
42.65%
129.74%
261.03%

ATH

ATH Price$95.95
ATH Date2023-10-06
% since ATH-22.41%
% to ATH28.88%

ATL

ATL Price$0.07
ATL Date2001-02-23
% from ATL112,023.49%
Last Low Price$68
Last Low Date2024-04-02
% From Last Low9.49%

IPO

IPO Price$0.00520000
% Current ROI USD1,431,730.77%
ATH Price$95.95
% ROI ATH 14,450,301.20%

[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="DEVA"]

Key Data [addtoany]

Current price	$74.45
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Today's High/Low	$74.5/$73.45
Volume	272,523.00
Previous Close	$74
52 Week High/Low	$101/$35.9048
Market Cap	14,891,414,528.00
P/E Ratio	15.4782
Forward P/E 1 Yr.	$0.00
Earnings Per Share(EPS)	$0
Annualized Dividend	$0.002

$74.45

[addtoany]

Deva Holding A.S. manufactures and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions.
It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, and sensory organs.
In addition, the company offers animal health products and active pharmaceutical ingredients, eye drops, medical ampoules for sterile injectable products, and cologne.
It also exports its products to approximately 60 countries. The company was founded in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of EastPharma SARL.

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31
Cash on hand	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	$159.82	$150.81	$93.84	$69.29	$240.63	$196.26	$179.96	$205.14	$182.31	$151.65	$165.50	$156.40	$134.30	$108.36	$122.53
Inventory	$430.76	$375.44	$215.64	$182.28	$185.39	$154.95	$146.15	$116.77	$109.13	$129.33	$97.94	$86.28	$68.35	$40.21	$38.50
Pre-Paid Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	$5.04	$23.64	$13.28	$17.01	$10.35	$19.62	$16.99	$13.98	$9.09	$44.39	$4.20	$4.44	$24.80	$12.50	$8.30
Total Current Assets	$1,241.27	$962.29	$621.51	$449.63	$475.77	$412.98	-	-	-	-	-	-	-	-	-
Property, Plant, And Equipment	$530.98	$401.54	$364.83	$324.18	$301.20	$298.28	$280.90	$262.22	$229.90	$193.97	$191.70	$185.30	$127.40	$84.87	$83.38
Long-Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill And Intangible Assets	$1.78	$1.78	$1.78	$1.78	$1.78	$1.78	$1.78	$1.78	$1.78	$1.78	$1.78	$1.78	-	$4.31	-
Other Long-Term Assets	$233.33	$173.82	$153.86	$148.35	$128.51	$115.86	$82.60	$51.14	$68.67	$48.50	$34.11	$29.53	$8.55	$10.59	$0.92
Total Long-Term Assets	$878.23	$706.15	$634.90	$567.89	-	-	-	-	-	-	-	-	-	-	-
Total Assets	$2,119.50	$1,668.44	$1,256.41	$1,017.53	$992.95	$893.53	$826.63	$723.26	$666.25	$622.80	$528.42	$489.79	$385.28	$290.88	$273.18
Total Current Liabilities	$670.47	$584.10	$418.74	$245.45	$463.41	$262.84	$221.71	$271.89	$231.42	$229.79	$183.94	$205.85	$100.77	$73.63	$115.10
Long Term Debt	$333.11	$284.71	$191.36	$225.56	$48.58	$197.21	$181.89	$53.88	$73.71	$44.47	$35.20	$24.59	$4.56	$16.57	$31.76
Other Non-Current Liabilities	$65.47	$53.22	$41.23	$33.68	$27.84	$21.57	$19.97	$18.85	$16.68	$8.71	$4.13	$3.81	$12.05	$10.16	$9.94
Total Long Term Liabilities	$418.19	$337.93	$232.58	$259.23	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	$1,088.66	$922.03	$651.32	$504.68	$539.84	$481.62	$423.58	$344.63	$321.81	$282.98	$223.27	$234.25	$117.38	$101.43	$158.68
Common Stock Net	$200.02	$200.02	$200.02	$200.02	$200	$200	$200	$200	$200	$180.07	$144	$48	$48	$48	$48
Retained Earnings (Accumulated Deficit)	$541.71	$258.12	$118.53	$25.99	$116.52	$68.86	$60.14	$35.54	$1.30	$16.91	$18.58	-	$135.64	-	$33.39
Comprehensive Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Share Holders Equity	$135.41	$134.71	$132.83	$133.13	$133.72	$140.13	-	-	-	-	-	-	-	-	-
Share Holder Equity	$1,030.84	$746.41	$605.09	$512.85	$453.11	$411.87	$402.99	$378.55	$344.37	$339.68	$305.01	$255.42	$267.88	$189.45	$114.50
Total Liabilities And Share Holders Equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31
Revenue	$1,373.98	$1,040.68	$800.30	$688.46	$576.38	$467.94	$418.39	$419.51	$404.97	$385.66	$332.64	$216.99	$267.27	$181.97	$230.28
Cost Of Goods Sold	$688.52	$543.19	$470.42	$425.08	$341.45	$278.81	$237.65	$229.24	$250.42	$244.18	$188.63	$145.08	$135.82	$101.56	$103.66
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development Expenses	$39.39	$35.78	$28.83	$11.96	$13.12	$4.43	$5.25	$4.57	$6.02	$3.56	$2.83	$5.67	-	$3.43	$2.50
SG&A Expenses	$83	$76.37	$55.95	$46.61	$137.98	$119.80	$118.37	$106.52	$137.48	$133.89	$119.95	$120.62	$98.91	$88.55	$80.65
Other Operating Income Or Expenses	$-0.66	$-5.55	$-8.96	$-5.03	$-6.11	$-2.41	-	-	-	-	-	-	-	-	-
Operating Expenses	$974.10	$790.96	$662.17	$573.78	$486.44	$425.82	-	-	-	-	-	-	-	-	-
Operating Income	$399.88	$249.72	$138.12	$114.68	$89.94	$42.12	$38.33	$62.68	-	$6.82	$6.92	-	$16.63	-	$37.17
Total Non-Operating Income/Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	$280.69	$155.97	$94.58	$71.98	$51.70	$5.05	$24.12	$41.21	-	-	-	-	$97.47	-	$21.89
Income Taxes	$-5.32	$19.61	$2.04	$11.64	$4.09	$-3.65	-	$6.96	$1.17	-	-	-	$6.89	-	$7.43
Income After Taxes	$-5.32	$19.61	$2.04	$11.64	$4.09	$-3.65	-	$6.96	$1.17	-	-	-	$6.89	-	$7.43
Other Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Continuous Operations	$286.02	$136.36	$92.54	$60.33	$47.62	$8.70	-	-	-	-	-	-	-	-	-
Income From Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	$286.02	$136.36	$92.54	$60.33	$47.66	$8.72	$24.60	$34.24	-	-	-	-	$90.61	-	$14.46
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	$399.88	$249.72	$138.12	$114.68	$89.94	$42.12	$38.33	$62.68	-	$6.82	$6.92	-	$16.63	-	$37.17
Basic Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31
Net Income/Loss	$286.02	$136.36	$92.54	$60.33	$47.66	$8.72	$24.60	$34.24	-	-	-	-	$90.61	-	$14.46
Total Depreciation And Amortization - Cash Flow	$46.09	$34.89	$30.89	$27.47	$26.67	$25.20	-	-	-	-	-	-	-	-	-
Change In Accounts Receivable	$-79.33	$-100.97	$-78.38	$29.95	$-44.52	$-16.32	$15.54	-	-	-	-	$22.51	-	$14.27	-
Change In Inventories	$-60.30	$-154.53	$-27.42	$-5.77	$-19.47	$-7.58	-	-	$24.70	-	-	-	-	-	$3.85
Cash Flow From Operating Activities	$441.24	$130.98	$110.84	$187.44	$88.58	$51.49	$50.04	$6.54	-	-	-	-	-	-	$6
Cash Flow From Investing Activities	$-208.97	$-156.96	$-113.20	$-99.37	$-77.96	$-73.44	-	-	-	-	$20.45	-	$58.03	-	-
Debt Issuance/Retirement Net - Total	$17.38	$144.31	$85.43	$-67.38	$14.38	$29.71	-	-	-	-	-	-	-	-	-
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	$-4.44	$-3.63
Financial Activities - Other	$-95.90	$-74.77	$-32.57	$-29.71	$-30.63	$-20.96	-	-	$0.32	-	-	-	-	-	-
Cash Flow From Financial Activities	$-78.52	$69.54	$52.86	$-97.09	$-16.25	$8.75	$57.57	$42.94	$62.67	-	$3.33	$147.45	$1.90	$31.09	$6.10
Net Cash Flow	$155.82	$43.31	$50.29	$-8.89	$-5.80	$-13.33	-	-	-	-	-	-	-	-	-
Common Stock Dividends Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	$-4.44	$-3.63